Cargando…

Regulation of microbiota—GLP1 axis by sennoside A in diet-induced obese mice

Sennoside A (SA) is a bioactive component of Chinese herbal medicines with an activity of irritant laxative, which is often used in the treatment of constipation and obesity. However, its activity remains unknown in the regulation of insulin sensitivity. In this study, the impact of SA on insulin se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le, Jiamei, Zhang, Xiaoying, Jia, Weiping, Zhang, Yong, Luo, Juntao, Sun, Yongning, Ye, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663941/ https://www.ncbi.nlm.nih.gov/pubmed/31384536 http://dx.doi.org/10.1016/j.apsb.2019.01.014

Ejemplares similares

Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice
por: Sun, Yongning, et al.
Publicado: (2018)

Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells
por: Ma, Li, et al.
Publicado: (2020)

Transcriptome Analysis of the Inhibitory Effect of Sennoside A on the Metastasis of Hepatocellular Carcinoma Cells
por: Le, Jiamei, et al.
Publicado: (2021)

Pharmacology, Toxicology, and Metabolism of Sennoside A, A Medicinal Plant-Derived Natural Compound
por: Le, Jiamei, et al.
Publicado: (2021)

The Effects and Mechanisms of Sennoside A on Inducing Cytotoxicity, Apoptosis, and Inhibiting Metastasis in Human Chondrosarcoma Cells
por: Le, Jiamei, et al.
Publicado: (2022)

Aquaporins Alteration Profiles Revealed Different Actions of Senna, Sennosides, and Sennoside A in Diarrhea-Rats
por: Cao, Yixin, et al.
Publicado: (2018)

Modulation of HIV-1 capsid multimerization by sennoside A and sennoside B via interaction with the NTD/CTD interface in capsid hexamer
por: Zhang, Da-Wei, et al.
Publicado: (2023)

Promotion of Intestinal Peristalsis by Bifidobacterium spp. Capable of Hydrolysing Sennosides in Mice
por: Matsumoto, Mitsuharu, et al.
Publicado: (2012)

Gastroprotective Activities of Sennoside A and Sennoside B via the Up-Regulation of Prostaglandin E(2) and the Inhibition of H(+)/K(+)-ATPase
por: Hwang, In Young, et al.
Publicado: (2015)

Determination of Total Sennosides and Sennosides A, B, and A(1) in Senna Leaflets, Pods, and Tablets by Two-Dimensional qNMR
por: Çiçek, Serhat Sezai, et al.
Publicado: (2022)

ATP reduces mitochondrial MECR protein in liver of diet-induced obese mice in mechanism of insulin resistance
por: Qian, Shengnan, et al.
Publicado: (2020)

Restoration of mRNA Expression of Solute Carrier Proteins in Liver of Diet-Induced Obese Mice by Metformin
por: Le, Jiamei, et al.
Publicado: (2021)

Gut Bacteria Selectively Altered by Sennoside A Alleviate Type 2 Diabetes and Obesity Traits
por: Wei, Zhonghong, et al.
Publicado: (2020)

Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice
por: Zhang, Feng, et al.
Publicado: (2021)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019)

Sennoside A drug capped biogenic fabrication of silver nanoparticles and their antibacterial and antifungal activities
por: Al-Ghamdi, Areej Dhawi, et al.
Publicado: (2020)

Response Surface Methodology (RSM)-Based Optimization of Ultrasound-Assisted Extraction of Sennoside A, Sennoside B, Aloe-Emodin, Emodin, and Chrysophanol from Senna alexandrina (Aerial Parts): HPLC-UV and Antioxidant Analysis
por: Alam, Perwez, et al.
Publicado: (2022)

Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1
por: van Gorkom, B A P, et al.
Publicado: (2002)

Organ Specific Differences in Alteration of Aquaporin Expression in Rats Treated with Sennoside A, Senna Anthraquinones and Rhubarb Anthraquinones
por: Wang, Zhaoyang, et al.
Publicado: (2021)

Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor
por: Goldsmith, Felicia, et al.
Publicado: (2015)

Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice
por: Shi, Hongli, et al.
Publicado: (2020)

Pleurotus Ostreatus Ameliorates Obesity by Modulating the Gut Microbiota in Obese Mice Induced by High-Fat Diet
por: Hu, Yanzhou, et al.
Publicado: (2022)

Design and Development of Mixed Film of Pectin: Ethyl Cellulose for Colon Specific Drug Delivery of Sennosides and Triphala
por: Momin, Munira, et al.
Publicado: (2008)

β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice
por: Shi, Hongli, et al.
Publicado: (2020)

The effect of gum chewing on blood GLP-1 concentration in fasted, healthy, non-obese men
por: Xu, Jianping, et al.
Publicado: (2015)

Ellagic acid and Sennoside B inhibit osteosarcoma cell migration, invasion and growth by repressing the expression of c-Jun
por: Xu, Wei, et al.
Publicado: (2018)

Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice
por: Clemmensen, Christoffer, et al.
Publicado: (2015)

Diet-Intestinal Microbiota Axis in Osteoarthritis: A Possible Role
por: Li, Yusheng, et al.
Publicado: (2016)

The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling
por: Xie, Zhifu, et al.
Publicado: (2020)

Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?
por: Meurot, C., et al.
Publicado: (2022)

Comparative effectiveness of lactulose and sennosides for the prevention of peritoneal dialysis-related peritonitis: an open-label, randomized, active-controlled trial
por: Noppakun, Kajohnsak, et al.
Publicado: (2021)

High β-Glucan Barley Supplementation Improves Glucose Tolerance by Increasing GLP-1 Secretion in Diet-Induced Obesity Mice
por: Suzuki, Sachina, et al.
Publicado: (2021)

Integrated analysis of the microbiota-gut-brain axis in response to sleep deprivation and diet-induced obesity
por: Lee, Jibeom, et al.
Publicado: (2023)

Diet-Microbiota-Brain Axis in Alzheimer’s Disease
por: Kincaid, Halle J., et al.
Publicado: (2021)

Exercise ameliorates the FGF21–adiponectin axis impairment in diet-induced obese mice
por: Yang, Wenqi, et al.
Publicado: (2019)

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
por: Cani, P D, et al.
Publicado: (2009)

Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice
por: Cui, Chenxi, et al.
Publicado: (2017)

Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice
por: Wei, Xiuqing, et al.
Publicado: (2014)

Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
por: Zhou, Liyuan, et al.
Publicado: (2019)

GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
por: Abdalqadir, Nyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2q9sm781ruut2gkavn259kaiiq